Search results

Page results

• Getting to Grips with Anxiety - Two-part online workshop

  This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.

• Hundreds attend Research Open Day

  Learn more about how UCLH celebrated Research Open Day this month.

• Breathing aids developed by UCL, UCLH and F1 team delivered to 40 NHS hospitals

  Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.

• Surviving coronavirus - patients speak about the impact of the disease

  Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.

• WEB Intracranial aneurysm device in the treatment of cerebral aneurysms

  This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms

• Covid-19 vaccine: Common stroke symptoms must be ‘urgently evaluated’

  UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.

• Molecular Radiotherapy Series No.5 – Information for adults having radioactive iodine (131I) treatment

  This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.

• Trial of innovative blood cancer treatment expanded

  A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.

• BBC documentary featuring UCLH clinicians highlights harms of ultra-processed food

  A BBC One documentary featuring clinicians at UCLH which airs this Thursday highlights the harm to the body and brain caused by ultra-processed food.

• UCLH recruits first participant in Europe to remdesivir outpatient study

  UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.